Clinical Scorecard: Patterns of Borderline Liver Enzyme Elevations and Their Associated Metabolic and Inflammatory Profiles: A Study in Outpatient Settings
At a Glance
Category
Detail
Condition
Borderline Liver Enzyme Elevations
Key Mechanisms
Hepatocellular and cholestatic patterns with distinct metabolic and inflammatory profiles.
Target Population
Adult outpatients with persistent borderline liver enzyme elevations.
Care Setting
Outpatient settings
Key Highlights
211 out of 800 patients exhibited borderline liver enzyme elevations.
Borderline cases were categorized into hepatocellular (49.8%), cholestatic (36.5%), and overlap (13.7%) patterns.
Hepatocellular pattern linked to higher ferritin and lower AST/ALT ratio.
Cholestatic pattern associated with higher HbA1c and systemic immune-inflammation index (SII).
A pattern-based approach may enhance outpatient management.
Guideline-Based Recommendations
Diagnosis
Use sex-specific ULN to classify liver enzyme elevations.
Management
Consider metabolic and inflammatory profiles in managing borderline liver enzyme elevations.
Monitoring & Follow-up
Follow-up with standardized fasting biochemistry and haematology panels.
Risks
Potential for misclassification of clinically significant liver conditions.
Patient & Prescribing Data
Adults with borderline liver enzyme elevations.
Distinct metabolic signatures may inform tailored management strategies.
Clinical Best Practices
Stratify borderline liver enzyme elevations into subphenotypes for better clinical insights.
Monitor ferritin levels in patients with hepatocellular patterns.
Evaluate HbA1c and SII in patients with cholestatic patterns.
Mayo Clinic Children's delivers comprehensive care for children with liver disease, from early evaluation and second opinions to advanced therapies and pediatric liver transplantation.
